Binimetinib trials for Metastatic Melanoma

All Binimetinib trials · All Metastatic Melanoma trials

Phase breakdown

Recruiting trials studying Binimetinib for Metastatic Melanoma

• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
  NCT04511013 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 331 locations
• Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
  NCT05026983 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
  NCT04903119 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

How many trials study Binimetinib for Metastatic Melanoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.